Researchers from the University of Oxford’s Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine.
Influenza is thought to be a highly variable virus, able to mutate and escape immunity built up in the population due to its circulation in previous seasons. However, influenza seasons tend to be dominated by a limited number of antigenically and genetically distinct influenza viruses. This creates a paradox as influenza is thought of as being highly variable while in reality influenza seasons are dominated by only a few strains.
Mathematical models produced in Professor Sunetra Gupta’s group at the University of Oxford over the past 20 years have sought to find an answer to this paradox. Finally, through a collaborative approach across multiple departments, the group believes they have the answer, demonstrated in a paper published today in Nature Communications.
Dr Craig Thompson said: ‘The integrated approach to vaccine design that we have applied to flu has to the potential to be applied to other previously intractable pathogens and could revolutionise the way we develop vaccines.’
Professor Sunetra Gupta said: ‘I think this work serves a good example of how evolutionary models can have translational impact. We have gone from a prediction of a mathematical model to a blueprint for a universal influenza vaccine. The outstanding teamwork coordinated by Dr Thompson is what made it all possible.’
The research team theorized that parts of the virus targeted by the immune system are, in fact, limited in variability and act as constraints on the evolution of the virus. Dr Craig Thompson in Professor Gupta’s group has now identified the location of these regions of limited variability. He has shown that such locations are targeted naturally by the immune system and through vaccination studies has shown that regions of influenza viruses that circulated in 2006 and 1977 were able to protect against infection with an influenza virus that last circulated in 1934.
The results of these studies can be exploited to create a novel type of ‘universal’ or broadly protective influenza vaccine, which once administered would provide lifelong protection against influenza. The team also hopes to apply the approach to other viruses such as HIV and HCV and believes that they can use it to produce a vaccine that protects against the common cold. The novel approach to vaccine design is outlined in the paper published in Nature Communications. Furthermore, such vaccines should be able to be produced in a low-cost manner, enabling healthcare providers such as the NHS to save money, unlike many new vaccines and drugs coming to the market.
This study also presents one of the first examples of where a mathematical model of the evolutionary dynamics of an infectious disease has led to the experimental identification of a novel vaccine target. The novel approach won an MRC Confidence in Concept Award in 2016, a Royal Society Translational Award in 2017 and an ERC Proof of Concept grant in 2018.
The WHO estimates that influenza kills 260,000-650,000 people and causes 3-5 million cases of severe illness each year. This burden typically falls on the elderly and young children, especially in developing countries. The best way to protect against influenza is through vaccination, although the problem with this is that the current influenza vaccine has to be administered each year and varies in its effectiveness.
Learn more: Pre-clinical success for universal flu vaccine offers hope
The Latest on: Universal flu vaccine
[google_news title=”” keyword=”universal flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Universal flu vaccine
- Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024on April 27, 2024 at 1:00 am
LHNVD-105, a universal influenza vaccine, shows strong immunogenicity at low doses in pigs, validating previous studies in rodents Monoclonal antibodies generated by LHNVD-105 demonstrates the need ...
- Bhutan closer to achieving universal immunisation coverage with 99.6 % children vaccinatedon April 26, 2024 at 7:08 am
Bhutan has made significant progress in achieving the Universal Immunisation coverage target. The country has vaccinated 99.6 per cent of children so far. This is according to data released by the ...
- Swine Flu Newson April 24, 2024 at 5:00 pm
Universal Flu Vaccine Protects Against Variants of Both Influenza A and B Viruses, Researchers Find Aug. 25, 2022 — A new universal flu vaccine protects against diverse variants of both ...
- Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Millionon April 24, 2024 at 9:05 am
The private placement provides $240 million in gross proceeds that will be used by Cidara to develop CD388 as a universal preventative against seasonal and pandemic influenza A and B, beginning with a ...
- Is There a Vaccine for H5N1 Influenza?on April 22, 2024 at 2:31 pm
On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...
- A Universal Vaccine Against Any Viral Variant? A New Study Suggests It’s Possibleon April 22, 2024 at 1:37 pm
A universal vaccine would train the body to recognize and eradicate new viral strains, even if they've mutated into nearly unrecognizable forms.
- A one-shot vaccine for COVID, flu and future viruses? Researchers say it's comingon April 18, 2024 at 3:43 pm
But what if it were possible to protect against COVID and the flu, and other unknown viruses that haven't yet emerged, with just one shot? If that became reality, seasonal or annual boosters would be ...
- Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruseson April 16, 2024 at 4:54 pm
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
- Universal vaccine may be effective against any variant of any viruson April 16, 2024 at 4:54 pm
Scientists at the University of California, Riverside (UCR) has recently developed a revolutionary RNA-based strategy for a universal vaccine ...
via Bing News